SCHEMBL3758192

SCHEMBL3758192

CCOC(=O)CNC(=O)c1c(OC)ccc2cccnc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.47
HSD17B10 Q99714 3/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 2/20 0.47
TP53 P04637 2/20 0.47
HTT P42858 2/20 0.47
LMNA P02545 4/20 0.44
MAPT P10636 2/20 0.44
EGLN1 Q9GZT9 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
RAB9A P51151 1/20 0.43
POLB P06746 1/20 0.43
MITF O75030 1/20 0.42
NFKB1 P19838 1/20 0.42
MAPK1 P28482 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3762383 0.81 EGLN3 (0.57) HPGDHSD17B10ALDH1A1LMNAMAPT
SCHEMBL1165232 0.80 SMN1; SMN2 (0.43) HPGDHSD17B10ALDH1A1KDM4ETP53
SCHEMBL11084416 0.75 HSP90AA1 (0.55) HPGDHSD17B10ALDH1A1KDM4ETP53
SCHEMBL3756602 0.75 SLC40A1 (0.52) HPGDALDH1A1KDM4ETP53HTT
SCHEMBL8625603 0.74 MAPT (0.62) HPGDHSD17B10ALDH1A1KDM4ETP53
SCHEMBL1165214 0.73 EGLN3 (0.59) HPGDHSD17B10ALDH1A1KDM4ETP53
SCHEMBL16039856 0.73 TP53 (0.49) HPGDHSD17B10ALDH1A1KDM4ETP53
SCHEMBL6985945 0.72 HPGD (0.57) HPGDHSD17B10ALDH1A1KDM4ETP53
SCHEMBL29601361 0.71 ALDH1A1 (0.51) HPGDHSD17B10ALDH1A1KDM4ELMNA
Hydrochloric Acid SCHEMBL8374272 0.71 LMNA (0.42) HPGDHSD17B10ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100305154-A1 Prolyl Hydroxylase Inhibitors GLAXOSMITHKLINE LLC 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305154-A1 Prolyl Hydroxylase Inhibitors HIF1AN, EGLN3, EGLN2 HPGD 58/4885HSD17B10 507/4885ALDH1A1 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.